Reply to Dr. Gentili' "Analysis of tolerance to antidepressant drugs in FDA Adverse Event Reporting System"

Affiliations

Comment

Michele Fornaro. Pharmacol Res. 2019 Mar.

. 2019 Mar:141:618.

doi: 10.1016/j.phrs.2018.12.012. Epub 2018 Dec 15.

¹ Department of Psychiatry, Federico II University of Naples, 80131, Italy. Electronic address: dott.fornaro@gmail.com.

No abstract available

Comment on

The emergence of loss of efficacy during antidepressant drug treatment for major depressive disorder: An integrative review of evidence, mechanisms, and clinical implications.
Fornaro M, Anastasia A, Novello S, Fusco A, Pariano R, De Berardis D, Solmi M, Veronese N, Stubbs B, Vieta E, Berk M, de Bartolomeis A, Carvalho AF. Fornaro M, et al. Pharmacol Res. 2019 Jan;139:494-502. doi: 10.1016/j.phrs.2018.10.025. Epub 2018 Oct 29. Pharmacol Res. 2019. PMID: 30385364 Review.
Analysis of tolerance to antidepressant drug treatment in FDA Adverse Event Reporting System.
Carnovale C, Gentili M, Viganò C, Carnaghi G, Beltrami M, Bosi M. Carnovale C, et al. Pharmacol Res. 2019 Mar;141:616-617. doi: 10.1016/j.phrs.2018.12.013. Epub 2018 Dec 15. Pharmacol Res. 2019. PMID: 30562572 No abstract available.